Differential effects of the tricyclic antidepressant desipramine on the density of adrenergic receptors in juvenile and adult rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 321, Issue 2, 2007, Pages 770-776

  Deupree, Jean D ^a   Reed, Abbey L ^a   Bylund, David B ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; DESIPRAMINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG MECHANISM; MALE; NEWBORN; NONHUMAN; OSMOTIC MINIPUMP; PERINATAL PERIOD; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION;

AGE FACTORS; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CEREBRAL CORTEX; DESIPRAMINE; MALE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 34247220429     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.118935     Document Type: Article

References (41)

1. Ambrosini PJ (2000) A review of pharmacotherapy of major depression in children and adolescents. Psychiatr Serv 51:627-633.
2. Argenti D and D'Mello AP (1994a) Design of a desipramine dosing regimen for the rapid induction and maintenance of maximal cortical beta-adrenoceptor down-regulation. Neuropharmacology 33:1117-1124.
3. Argenti D and D'Mello AP (1994b) The pharmacodynamics of desipramine and desmethyldesipramine in rats. J Pharmacol Exp Ther 270:512-519.
4. Beer M, Hacker S, Poat J, and Stahl SM (1987) Independent regulation of beta-1 and beta-2 adrenoceptors. Br J Pharmacol 92:827-834.
5. Birmaher B, Ryan ND, Williamson DE, Brent DA, and Kaufman J (1996) Childhood and adolescent depression: a review of the past 10 years. Part II. J Am Acad Child Adolesc Psychiatry 35:1575-1583.
6. Birmaher B, Waterman GS, Ryan ND, Perel J, McNabb J, Balach L, Beaudry MB, Nasr FN, Karambelkar J, Elterich G, et al. (1998) Randomized, controlled trial of amitriptyline versus placebo for adolescents with "treatment- resistant" major depression. J Am Acad Child Adolesc Psychiatry 37:527-535.
7. Blakemore SJ and Choudhury S (2006) Development of the adolescent brain: implications for executive function and social cognition. J Child Psychol Psychiatry 47:296-312.
8. Callado LF, Meana JJ, Grijalba B, Pazos A, Sastre M, and Garcia-Sevilla JA (1998) Selective increase of alpha2A-adrenoceptor agonist binding sites in brains of depressed suicide victims. J Neurochem 70:1114-1123.
9. 3H]RX821002 to the α-2 adrenergic receptor subtypes. J Pharmacol Exp Ther 278:1215-1227.
10. Giralt MT and Garcia-Sevilla JA (1989) Acute and long-term regulation of brain alpha-2 adrenoceptors after manipulation of noradrenergic transmission in the rat. Eur J Pharmacol 164:455-466.
11. Goodnough DB and Baker GB (1994) 5-Hydroxytryptamine2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination. J Neurochem 62:2262-2268.
12. Happe HK, Coulter CL, Gerety ME, O'Rourke MF, Bylund DB, and Murrin LC (2004) alpha-2 Adrenergic receptor development in rat CNS: an autoradiographic study. Neuroscience 123:167-178.
13. Harden TK, Wolfe BB, Sporn JR, Perkins JP, and Molinoff PB (1977) Ontogeny of beta-adrenergic receptors in rat cerebral cortex. Brain Res 125:99-108.
14. Kessler RC, Avenevoli S, and Ries MK (2001) Mood disorders in children and adolescents: an epidemiologic perspective. Biol Psychiatry 49:1002-1014.
15. Kozisek M, Deupree J, Burke W, and Bylund D (2007) Appropriate dosing regimens for treating juvenile rats with desipramine for neuropharmacological and behavioral studies. J Neurosci Methods, in press.
16. Kozisek ME, Deupree JD, Murrin LC, Happe HK, Middlemas D, and Bylund DB (2006) Effects of desipramine and escitalopram on BDNF levels in juvenile and adult rats, in 2006 Neuroscience Meeting Planner; 2006 Oct 14-18; Atlanta, GA. Program no. 287.13, Society for Neuroscience, Washington, DC.
17. Kratochvil CJ, Vitiello B, Walkup J, Emslie G, Waslick BD, Weller EB, Burke WJ, and March JS (2006) Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable? J Child Adolesc Psychopharmacol 16:11-24.
18. Kye CH, Waterman GS, Ryan ND, Birmaher B, Williamson DE, Iyengar S, and Dachille S (1996) A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression. J Am Acad Child Adolesc Psychiatry 35:1139-1144.
19. Maes M, Van Gastel A, Delmeire L, and Meltzer HY (1999) Decreased platelet alpha-2 adrenoceptor density in major depression: effects of tricyclic antidepressants and fluoxetine. Biol Psychiatry 45:278-284.
20. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, et al. (2004) Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: treatment for Adolescents With Depression Study (TADS) randomized controlled trial. J Am Med Assoc 292:807-820.
21. Maul A, Happe HK, Petty F, and Bylund DB (2005) Animal behavioral models of depression in 21-day-old and younger juvenile rats, in 2005 Neuroscience Meeting Planner; 2005 Nov 12-16; Atlanta, GA. Program no. 319.6. Society for Neuroscience, Washington, DC.
22. Maul AL, Happe HK, Petty F, and Bylund DB (2006) Assessment of forced swim and tail suspension with juvenile rats as models of antidepressant drug efficacy for childhood and adolescent depression. Acta Pharmacological Sinoca 93:P060009.
23. 2-Adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression. Biol Psychiatry 31:471-490.
24. Menkes DB and Aghajanian GK (1981) α1-Adrenoceptor-mediated responses in the lateral geniculate nucleus are enhanced by chronic antidepressant treatment. Eur J Pharmacol 74:27-35.
25. Menkes DB, Kehne JH, Gallager DW, Aghajanian GK, and Davis M (1983) Functional supersensitivity of CNS [alpha]1-adrenoceptors following chronic antidepressant treatment. Life Sci 33:181-188.
26. Murrin L, Sanders JD, and Bylund DB (2007) Comparison of the maturation of the adrenergic and serotonergic neurotransmitter systems in the brain: potential insights into childhood and adolescent depression. Biochem Pharmacol 73:1225-1236.
27. 3H]CGP-12177 binding reveals rapid (24 hour) modulation. Brain Res Bull 41:93-96.
28. Ordway GA, Schenk J, Stockmeier CA, May W, and Klimek V (2003) Elevated agonist binding to alpha2-adrenoceptors in the locus coeruleus in major depression. Biol Psychiatry 53:315-323.
29. Pittman RN, Minneman KP, and Molinoff PB (1980) Ontogeny of beta-1 and beta-2 adrenergic receptors in rat cerebellum and cerebral cortex. Brain Res 188:357-368.
30. Rehavi M, Ramot O, Yavetz B, and Sokolovsky M (1980) Amitriptyline: long-term treatment elevates alpha-adrenergic and muscarinic receptor binding in mouse brain. Brain Res 194:443-453.
31. Sacchetti G, Bernini M, Gobbi M, Parini S, Pirona L, Mennini T, and Samanin R (2001) Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic alpha2-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 363:66-72.
32. Sanders JD, Happe HK, Bylund DB, and Murrin LC (2005) Development of the norepinephrine transporter in the rat CNS. Neuroscience 130:107-117.
33. 2A- adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety. J Neurosci 21:4875-4882.
34. Scott JA and Crews FT (1983) Rapid decrease in rat brain beta adrenergic receptor binding during combined antidepressant α-2 antagonist treatment. J Pharmacol Exp Ther 224:640-646.
35. Sethy VH, Day JS, and Cooper MM (1988) Dose-dependent down-regulation of beta-adrenergic receptors after chronic intravenous infusion of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 12:673-682.
36. Slotkin TA, Kudlacz EM, Lappi SE, Tayyeb MI, and Seidler FJ (1990) Fetal terbutaline exposure causes selective postnatal increases in cerebellar alpha-adrenergic receptor binding. Life Sci 47:2051-2057.
37. Smith CB, Garcia-Sevilla JA, and Hollingsworth PJ (1981a) alpha 2-Adrenoreceptors in rat brain are decreased after long-term tricyclic antidepressant drug treatment. Brain Res 210:413-418.
38. Smith CB, Garcia-Sevilla JA, and Hollingsworth PJ (1981b) alpha 2-adrenoreceptors in rat brain are decreased after long-term tricyclic antidepressant drug treatment. Brain Res 210:413-418.
39. Subhash MN, Nagaraja MR, Sharada S, and Vinod KY (2003) Cortical alpha-adrenoceptor downregulation by tricyclic antidepressants in the rat brain. Neurochem Int 43:603-609.
40. Tang SW, Seeman P, and Kwan S (1981) Differential effect of chronic desipramine and amitriptyline treatment on rat brain adrenergic and serotonergic receptors. Psychiatry Res 4:129-138.
41. Weller EB and Weller RA (2000) Treatment options in the management of adolescent depression. J Affect Disord 61:S23-S28.